Zentalis Pharmaceuticals (ZNTL) Receivables - Net (2019 - 2024)
Zentalis Pharmaceuticals' (ZNTL) quarterly Receivables - Net came in at $5.0 million in Q4 2024, up 124900.0% quarter-over-quarter from $4000.0 in Q4 2021.
Zentalis Pharmaceuticals (ZNTL) Receivables - Net (2019 - 2024) Analysis & Trends
Zentalis Pharmaceuticals' Receivables - Net history runs 4 years deep, the most recent figure standing at $5.0 million for Q4 2024.
- On a quarterly basis, Receivables - Net changed N/A year-over-year to $5.0 million in Q4 2024; TTM through Dec 2024 was $5.0 million, a N/A change from a year earlier, with the FY2024 full-year figure at $5.0 million, changed N/A from the prior year.
- Receivables - Net advanced to $5.0 million in Q4 2024 per ZNTL's latest filing, from $4000.0 in the prior quarter.
- Across five years, Receivables - Net topped out at $5.0 million in Q4 2024 and bottomed at $4000.0 in Q4 2021.
- The 3-year median for Receivables - Net is $122000.0 (2020), against an average of $679555.6.
- Across the five-year window, Receivables - Net soared 197.86% in 2020 and sank 99.04% in 2021, its largest moves.
- Year by year, Receivables - Net stood at $417000.0 in 2020, then sank by 99.04% to $4000.0 in 2021, then soared by 124900.0% to $5.0 million in 2024.
- Per Business Quant, the three latest ZNTL Receivables - Net figures stand at $5.0 million (Q4 2024), $4000.0 (Q4 2021), and $108000.0 (Q3 2021).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Zentalis Pharmaceuticals | 312.67 Mn | 312.67 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | 5.00 Mn |
| Dec 31, 2024 | 5.00 Mn |
| Dec 31, 2021 | 4,000.00 |
| Dec 31, 2021 | 4,000.00 |
| Sep 30, 2021 | 108,000.00 |
| Sep 30, 2021 | 108,000.00 |
| Jun 30, 2021 | 5,000.00 |
| Jun 30, 2021 | 5,000.00 |
| Mar 31, 2021 | 248,000.00 |
| Mar 31, 2021 | 248,000.00 |
| Dec 31, 2020 | 417,000.00 |
| Dec 31, 2020 | 417,000.00 |
| Sep 30, 2020 | 122,000.00 |
| Sep 30, 2020 | 122,000.00 |
| Jun 30, 2020 | 73,000.00 |
| Jun 30, 2020 | 73,000.00 |
| Mar 31, 2020 | 139,000.00 |
| Mar 31, 2020 | 139,000.00 |
| Dec 31, 2019 | 140,000.00 |
| Dec 31, 2019 | 140,000.00 |